Literature DB >> 6303074

Effects of thromboxane antagonist EP 045 on platelet aggregation.

R L Jones, N H Wilson, R A Armstrong, V Peesapati, G M Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6303074

Source DB:  PubMed          Journal:  Adv Prostaglandin Thromboxane Leukot Res        ISSN： 0732-8141


× No keyword cloud information.
  6 in total

Review 1.  Current concepts for a drug-induced inhibition of formation and action of thromboxane A2.

Authors:  H Patscheke
Journal:  Blut       Date:  1990-05

2.  Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon.

Authors:  I A Reilly; L Roy; G A Fitzgerald
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-19

3.  Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.

Authors:  T M Connolly; L E Limbird
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

4.  Competitive antagonism at thromboxane receptors in human platelets.

Authors:  R A Armstrong; R L Jones; V Peesapati; S G Will; N H Wilson
Journal:  Br J Pharmacol       Date:  1985-03       Impact factor: 8.739

5.  Actions of the novel thromboxane A2 antagonists, ONO-1270 and ONO-3708, on smooth muscle cells of the guinea-pig basilar artery.

Authors:  M Fujioka; T Nagao; H Kuriyama
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-12       Impact factor: 3.000

6.  Ligand binding to thromboxane receptors on human platelets: correlation with biological activity.

Authors:  R A Armstrong; R L Jones; N H Wilson
Journal:  Br J Pharmacol       Date:  1983-08       Impact factor: 8.739
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.